Caribou Biosciences (CRBU) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CRBU Caribou Biosciences

Watchlist

2.020
+0.040+2.02%

Close Nov 22 16:00 ET

2.000
-0.020-0.99%

Post 20:01 ET

182.92MMarket Cap-1216P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Caribou Biosciences Reports Q3 2024 Financial Results
TipRanksNov 21 22:54 ET
Caribou Biosciences to Participate in Upcoming Investor Conferences
GlobeNewswireNov 20 16:00 ET
H.C. Wainwright Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $9
Moomoo NewsNov 15 06:34 ET · Ratings
Express News | HC Wainwright & Co. Reiterates Buy on Caribou Biosciences, Maintains $9 Price Target
BenzingaNov 15 06:19 ET
Analysts Are Updating Their Caribou Biosciences, Inc. (NASDAQ:CRBU) Estimates After Its Third-Quarter Results
Simply Wall StNov 10 08:17 ET
Caribou Biosciences' Strategic Advancements and Financial Efficiency Bolster Buy Rating
TipRanksNov 8 02:29 ET · Ratings

Comments

Stock_Drift

Sep 25 08:16

$Caribou Biosciences (CRBU.US)$

FattyChick

Sep 13 12:24

Next 3 stocks keeping an eye on.

$Caribou Biosciences (CRBU.US)$
$Gossamer Bio (GOSS.US)$
$Archer Aviation (ACHR.US)$
Gonna add a position for each again.

Trytosaveabit

Sep 3 07:01

News

$Caribou Biosciences (CRBU.US)$ Reuters· just
Caribou Biosciences Announces the FDA Has Granted Fast Track Designations to CB-010 in Refractory Sle and to CB-012 in Relapsed or Refractory Aml

Jaguar8

Jun 2 20:24

NEWS

$Caribou Biosciences (CRBU.US)$
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Caribou Biosciences presented promising clinical data from its CB-010 ANTLER Phase 1 trial at the 2024 ASCO Annual Meeting. CB-010, an allogeneic CAR-T cell therapy with partial HLA matching, showed potential to rival currently approved autologous CAR-T therapies in safety an...

Trytosaveabit

Apr 16 05:31

Hmm?

$Caribou Biosciences (CRBU.US)$ Got a inverted hammer on the daily! Its wick actually broke above the downtrend continuation wedge! Its Really OS RSI 7 = 14.58! RSI 14 = 24.96! MACD Looks as if its fixing to GC? So lets just see how this turns out? Just thinking outloud